Skip to content
Author
PUBLISHED: | UPDATED:
Getting your Trinity Audio player ready...

Following is a summary of current health news briefs.

L.A.’s richest man ups the ante for city, cancer fight

LOS ANGELES (Reuters) – As owner of 5 percent of the Los

Angeles Lakers, Patrick Soon-Shiong could walk into the locker

room of the storied basketball franchise any time for a chat

with stars like Kobe Bryant. But the richest man in Los Angeles

chooses to sit with the rest of his team’s fans. “He’s not one

of those owners who wants to be seen everywhere. He’s just one

of the fans,” said Bryant. The NBA star gives his owner a hug

before every game for luck “and maybe some of the success” of

the slender Los Angles surgeon who built a fortune exceeding $7

billion as a biotechnology entrepreneur.

Tennessee fungal meningitis outbreak spreads to other

states

NASHVILLE (Reuters) – State and federal health officials

said on Wednesday that they expected more cases to be reported

in a deadly outbreak of fungal meningitis they believe is

linked to steroid injections given for pain at two clinics in

Tennessee. So far two people have died and 18 others have been

sickened in Tennessee from meningitis linked to the outbreak.

Four other states have reported cases, with a total of 26

illnesses and four deaths, said Centers for Disease Control and

Prevention spokesman Curtis Allen.

Moderate drinking linked to abnormal heart rhythm

NEW YORK (Reuters Health) – People with heart disease who

drink, even moderately, may have a slightly increased risk of a

common heart rhythm problem, a new study suggests. The study is

not the first to link moderate drinking to the heart

arrhythmia, known as atrial fibrillation (AF). But it’s still

not clear that the habit, itself, is the problem.

Alere reaches deal with FDA on manufacture of cardiac test

2012-10-03T174200Z_1_BRE892141_RTROPTC_0_US-ALERE-FDA.XML

() –

Common solvents tied to birth defects

NEW YORK (Reuters Health) – Pregnant women with frequent

exposure to solvents at work may be at higher risk of having

babies with birth defects, French researchers have found. Both

self-reported exposure and urine samples supported the link

between the chemicals and newborn malformations such as cleft

palate and limb deformities, they report in the journal

Epidemiology.

Drop in hospital visits seen with lower drug copay

NEW YORK (Reuters Health) – After Pitney Bowes Inc cut

copayments for two essential heart drugs, employees at the

Stamford, Connecticut-based company began filling their

prescriptions more regularly, according to a new report. They

also were less likely to visit the doctor, end up in the ER or

be admitted to a hospital, slashing their out-of-pocket

expenses beyond the copay reductions, researchers found.

Infant fussiness not tied to later mental health

NEW YORK (Reuters Health) – Babies who fuss and cry a lot

may not have a greater chance of mental health issues later in

life – despite what their mothers might think, a new study

suggests. Parents sometimes worry that if their baby seems

overly irritable, that could be an omen of distress later in

life, too.

Merck’s once-a-week diabetes drug effective in clinical

study

2012-10-03T125153Z_1_BRE8920MH_RTROPTC_0_US-DIABETES-MERCK.XML

() –

Alipes launches sale of Nordic optician group Synsam:

sources

STOCKHOLM (Reuters) – The owners of Nordic optician chain

Synsam are launching a sale of the company which could fetch

around 500 million euros, sources familiar with the matter told

Reuters. The people, who are corporate finance advisors, said

on Wednesday that information about the firm will be sent to

potential buyers within days.

Sanofi, Bristol shake up alliance as patents end

PARIS (Reuters) – Drugmakers Sanofi and

Bristol-Myers Squibb plan to revamp their 15-year-old

alliance from January 1 in response to lost exclusivity on two

key drugs and the arrival of generic competition in major

markets. The move will see Bristol-Myers return rights to blood

clot preventer Plavix and blood pressure treatment

Avapro/Avalide to the French drugmaker in all markets, the

companies said in a joint statement on Wednesday.